U.S. pharmaceutical industry

The Statista dossier
  • Detailed references
  • Editorially prepared
  • Download as PDF / PPT

Statista dossier about the U.S. pharmaceutical industry

This dossier presents graphs and tables about the U.S. pharmaceutical industry. The U.S. pharma industry has a huge influence on the global pharmaceutical market. This document includes some of the most important key figures on U.S. revenues, top companies, top products, medicine use facts, research and development, and an outlook for the coming years.

Table of contents

  • 1. Contribution to global pharma

    • World pharmaceutical market distribution by submarket 2014-2020

    • World pharmaceutical sales 2017-2020 by region

    • Market share of the leading 10 global pharmaceutical markets 2019

    • Top global pharmaceutical markets: growth rate 2013-2019

    • Top 50 pharmaceutical companies - Rx sales and R&D spending 2019

    • Worldwide biopharma M&A transaction volume by location 2015-2019

  • 2. Overview

    • U.S. total medicine spending 2002-2019

    • Leading therapy areas for U.S. drug spending 2019

    • U.S. top 20 prescribed drugs based on sales 2019

    • Top pharma products by prescriptions U.S. 2019

    • Pharmaceutical channel distribution by U.S. spending 2017-2019

    • U.S. biopharmaceutical export volume 2002-2019

  • 3. Companies

    • 2020 list of top U.S. biotech and pharmaceutical companies based on revenue

    • Johnson & Johnson's total sales 2005-2020

    • Pfizer's total revenue 2006-2020

    • Merck & Co - total revenue 2006-2020

    • Pharmaceutical corporations by U.S. revenue 2019

  • 4. Research and development

    • Research and development expenditure: U.S. pharmaceutical industry 1995-2019

    • U.S. pharma industry R&D spending as a percent of total revenues 1990-2019

    • Biopharma medicines in development in 2020, by select category

    • Pharmaceuticals: cost of drug development in the U.S. since 1975

    • Number of novel drugs approved annually by CDER 2008-2020

    • Number of orphan designations accepted in the U.S. 2003-2020

    • U.S. sales growth of new brand medicines 2014-2019

    • R&D expenditure per employee in U.S. sectors 2003-2017

  • 5. Generics

    • Unbranded generics revenue top corporations in U.S. 2017-2018

    • Spending change on branded and generic medicines in the U.S. 2014-2019

    • U.S. brand and generic prescription drug revenue 2005-2019

    • Branded vs. generic U.S. drug prescriptions dispensed 2005-2019

    • Savings through generic drug usage in the U.S. 2008-2019

    • Projected decrease in brand drug spending due to patent loss in the U.S. 2014-2024

  • 6. Outlook

    • World pharmaceutical sales by region forecast 2024

    • Top branded biologic drugs in the U.S. that will go generic by 2028

    • Leading U.S. pharmaceutical products by revenue 2026

    • Projected 2024 revenue for top drugs approved U.S. 2018

    • U.S. cannabinoid-based pharmaceuticals market size 2020-2029 projection

Order dossier
More than 7,500
companies trust
Statista

Recommended studies and dossiers

Recent studies and dossiers

You may also be interested in...

Any more questions?

Get in touch with us quickly and easily.
We are happy to help!

Contact
Esther Shaulova
Operations Manager
support@statista.com +1 (212) 419-5770

Mon - Fri, 9am - 6pm, EST

Contact (Europe)
Lodovica Biagi
Director of Operations
eu.support@statista.com +44 (0)20 8189 7000

Mon - Fri, 9:30am - 5pm, GMT

New

All Dossiers for free within the Project Account

Order a Project Account now to get immediate access to our dossiers, studies and reports.

Get Project Account
No Thanks, order dossier

Statista Project Account

  • Immediate access to dossiers, reports and studies
  • Unlimited access to statistics, Market Outlooks and forecasts
  • No subscription (30 days duration)

Download your Report

We value your privacy and will never rent or sell your email address.

Privacy

Menu